SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-072409
Filing Date
2022-11-14
Accepted
2022-11-14 17:16:26
Documents
5
Effectiveness Date
2022-11-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea168653-s8_inmedpharma.htm S-8 46630
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEI ea168653ex5-1_inmedpharma.htm EX-5.1 17451
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea168653ex23-1_inmedpharma.htm EX-23.1 1871
4 FILING FEE TABLE ea168653ex-fee_inmedpharma.htm EX-FILING FEES 13875
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3956
  Complete submission text file 0001213900-22-072409.txt   86419
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-268356 | Film No.: 221387671
SIC: 2834 Pharmaceutical Preparations